CAN YOU TAKE GLP-1 MEDICATIONS AND TRT TOGETHER?

The Combination Question Men Are Asking

If you’re a man dealing with both obesity and low testosterone, you’ve probably wondered: can I take a GLP-1 medication and TRT at the same time? It’s one of the most common questions in men’s health forums, and the answer is nuanced.

The short version: yes, you can take them together, and some providers specifically offer both. But the more important question is whether you should — and the emerging research suggests that for many men, GLP-1 therapy alone may eliminate the need for TRT entirely.

The Case for GLP-1 First

A pivotal ENDO 2025 study tracked 110 men with obesity or type 2 diabetes on GLP-1 medications for 18 months. The proportion with normal testosterone levels (above 300 ng/dL) rose from 53% to 77%. Total testosterone increased from 312 ng/dL to 368 ng/dL on average.

The mechanism is straightforward: visceral fat contains aromatase enzymes that convert testosterone to estrogen. Lose the fat, keep more testosterone. GLP-1s restore the body’s natural hormonal axis rather than replacing it from the outside.

A separate ENDO 2025 study compared tirzepatide directly to transdermal testosterone in 83 men with functional hypogonadism. Tirzepatide delivered superior weight loss (8.1% vs. 3.0%), better waist circumference reduction, and improved erectile function — while increasing gonadotropins (LH and FSH), indicating it restored natural hormone production rather than suppressing it.

When the Combination Makes Sense

There are legitimate scenarios where combining GLP-1 and TRT is appropriate:

• Confirmed organic hypogonadism: If your low testosterone has a cause beyond obesity (pituitary disorder, Klinefelter syndrome, prior testicular injury), GLP-1-driven weight loss won’t fix the underlying problem.
• Inadequate response after 6+ months: If you’ve lost significant weight on a GLP-1 but your testosterone levels remain clinically low, adding TRT may be warranted.
• Severe symptoms requiring immediate intervention: Some men have testosterone so low that waiting 6–12 months for GLP-1-driven recovery isn’t practical. Starting both simultaneously can provide symptom relief while addressing root cause.

Providers That Offer Both

Not all GLP-1 telehealth platforms offer testosterone therapy. If you want the option to add TRT through the same provider, these platforms support both:

• MangoRx — Full men’s health platform with GLP-1s, TRT, ED medications, and hair loss treatments
• Hone Health — Hormone optimization platform that specifically pairs GLP-1s with TRT monitoring
• Fella Health — Men’s health focused with enclomiphene (a fertility-preserving alternative to TRT) available alongside GLP-1s

Having both options under one provider means seamless lab monitoring, coordinated dosing, and no gaps in care.

The Bottom Line

For most men with obesity-related low testosterone, the evidence points to trying GLP-1 therapy first. The ENDO 2025 data shows that 77% of obese men normalized their testosterone through GLP-1-driven weight loss alone — without the fertility risks, testicular shutdown, and lifelong dependency that comes with TRT.

If you’re currently on TRT and considering adding a GLP-1, or if you’re starting from scratch and trying to decide which treatment to pursue first, bring the ENDO 2025 data to your next doctor’s appointment. The conversation is shifting, and the evidence is on the side of addressing obesity first.